A detailed history of Larson Financial Group LLC transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Larson Financial Group LLC holds 1 shares of LNTH stock, worth $91. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1
Holding current value
$91
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 07, 2025

BUY
$76.22 - $116.71 $76 - $116
1 New
1 $0
Q4 2023

Feb 01, 2024

BUY
$55.6 - $77.89 $4,948 - $6,932
89 Added 80.18%
200 $12,000
Q3 2023

Nov 03, 2023

BUY
$60.27 - $90.75 $662 - $998
11 Added 11.0%
111 $7,000
Q2 2023

Aug 03, 2023

BUY
$82.41 - $99.65 $8,241 - $9,965
100 New
100 $8,000
Q2 2022

Aug 04, 2022

BUY
$55.54 - $72.65 $12,829 - $16,782
231 New
231 $15,000

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $6.29B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Larson Financial Group LLC Portfolio

Follow Larson Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Larson Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Larson Financial Group LLC with notifications on news.